Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Hepatology Communications|March 11, 2026
The rate and predictors of recompensation in patients with decompensated cirrhosis due to metabolic dysfunction-associated liver disease (MASLD)Alba Jiménez-Masip, M Teresa Broquetas, Sergio Muñoz-Martinez, et al.
Journal of Medical Virology|February 4, 2025
Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization InhibitorsErika Zodda, Mònica Pons, Natàlia DeMoya-Valenzuela, et al.
Gastroenterologia Y Hepatologia|November 26, 2022
Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetesJesús Rivera-Esteban, Mònica Pons, Alejandra Planas, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Assessing Liver Fibrosis Using the FIB4 Index in the Community SettingAlbert Blanco-Grau, Pablo Gabriel-Medina, Francisco Rodriguez-Algarra, et al.
Stem Cells (Dayton, Ohio)|May 6, 2016
Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition ProgramEsther Aguilar, Igor Marin de Mas, Erika Zodda, et al.
Nature Reviews. Gastroenterology & Hepatology|July 17, 2024
A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
Gastroenterology|November 10, 2025
The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver DiseaseLaia Aceituno, Juan Bañares, Mònica Pons, et al.
Journal of Hepatology|October 25, 2025
Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysisJuan Bañares, Mònica Pons, Thomas Reiberger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 13, 2023
Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver DiseaseMònica Pons, Jesús Rivera-Esteban, Mang M Ma, et al.
Molecular Cancer|October 22, 2014
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulationsFrancesca Mateo, Oscar Meca-Cortés, Toni Celià-Terrassa, et al.
Pageof 4